Sector Investors News and Insights

BIIB

ETFsector.com Daily Trading Outlook, January 15, 2025

S&P futures are up 0.3% in Wednesday morning trading after US equities closed mostly higher on Tuesday. Gains were led by small caps, banks, commodity equities, capital goods, builders, and airlines, while big tech and healthcare continued to lag. Treasuries are firmer across the curve, the dollar index is down 0.2%, gold is up 1%, […]

ETFsector.com Daily Trading Outlook, January 15, 2025 Read More »

, , , , , , , , , , , , , , , , , , ,

Bragar Eagel & Squire, P.C. advises investors that class action lawsuits have been initiated against Biogen, Charge, Fastly, and NIKE. Investors are urged to get in touch with the firm.

In New York on June 27, 2024, Bragar Eagel & Squire, P.C., a well-known law firm specializing in shareholder rights, is reminding investors about ongoing class action lawsuits on their behalf.

Bragar Eagel & Squire, P.C. advises investors that class action lawsuits have been initiated against Biogen, Charge, Fastly, and NIKE. Investors are urged to get in touch with the firm. Read More »

, , ,

Eisai and Biogen have announced that the FDA has accepted their supplemental Biologics License Application for monthly LEQEMBI IV maintenance dosing.

Visit thefly.com to stay updated on the latest financial news in real-time. The website is renowned for its market intelligence and offers a streaming news feed to keep readers informed.

Eisai and Biogen have announced that the FDA has accepted their supplemental Biologics License Application for monthly LEQEMBI IV maintenance dosing. Read More »

Robbins LLP is encouraging BIIB investors who have experienced significant losses to reach out to the firm for details regarding the Biogen Inc. Class Action.

Robbins LLP is alerting investors that a class action lawsuit has been filed by a shareholder on behalf of those who bought or acquired Biogen Inc. securities between February 3…

Robbins LLP is encouraging BIIB investors who have experienced significant losses to reach out to the firm for details regarding the Biogen Inc. Class Action. Read More »

,

Robbins LLP is encouraging BIIB investors who have experienced significant losses to reach out to the firm to learn more about the class action lawsuit involving Biogen Inc.

Robbins LLP informs investors that a shareholder has filed a class action lawsuit on behalf of individuals and entities who bought or obtained Biogen Inc. (NASDAQ: BIIB) securities between February 3…

Robbins LLP is encouraging BIIB investors who have experienced significant losses to reach out to the firm to learn more about the class action lawsuit involving Biogen Inc. Read More »

,

BIOGEN ALERT: Bragar Eagel & Squire, P.C. is reminding investors about a class action lawsuit against Biogen Inc. and is encouraging investors to reach out to the firm.

In New York on June 1, 2024, Bragar Eagel & Squire, P.C., a well-known firm specializing in stockholder rights, is reminding investors about a class action lawsuit that has been filed against…

BIOGEN ALERT: Bragar Eagel & Squire, P.C. is reminding investors about a class action lawsuit against Biogen Inc. and is encouraging investors to reach out to the firm. Read More »

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com